Начало・Списък с акции・Zealand Pharma A-S

Zealand Pharma A-S

Затворен

302.8 -1.53

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

303.5

Максимум

309.3

Ключови измерители
By Trading Economics
Приходи	4.3B 3.9B
Продажби	4.5B 4.5B
P/E Средно за сектора	7.665 56.659
EPS	55.34
Марж на печалбата	87.219
Служители	578
EBITDA	4.2B 3.9B

Препоръки
By TipRanks
Препоръки	Неутрален
12-месечна прогноза	+25.15% upside

Дивиденти
By Acuity
Следващи печалби	12.11.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-1.9B 20B
Предишно отваряне	304.33
Предишно затваряне	302.8

Zealand Pharma A-S Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

7.09.2026 г., 23:51 ч. UTC

Australia's Consumer Confidence Index set for release amid mixed market sentiment and rising interest rate concerns.

7.09.2026 г., 23:51 ч. UTC

Australia's Westpac Consumer Confidence Index set for release on September 8, amid cautious optimism in the stock market despite global economic uncertainties.

7.09.2026 г., 23:51 ч. UTC

UK Retail Sales Growth Slows to 0.5% YoY, Falling Short of Expectations Amid Consumer Caution

7.09.2026 г., 23:51 ч. UTC

U.S. Initial Jobless Claims Expected at 205,000 Amid Strong Labor Market and Anticipated Fed Rate Hikes

7.09.2026 г., 23:51 ч. UTC

China's Producer Prices Index Expected to Rise 3.7% Amid Mixed Economic Signals Ahead of September Release

7.09.2026 г., 23:41 ч. UTC

Japan's Q2 2026 GDP Growth Rate Expected at 0.4% Amid Optimistic Economic Sentiment and Rising Nikkei Index

7.09.2026 г., 23:41 ч. UTC

Japan's Q2 2026 GDP Growth Expected at +1.1% Amid Positive Economic Trends and Optimistic Market Sentiment

7.09.2026 г., 23:41 ч. UTC

Japan's Current Account Expected at JPY 2,870 Billion Amid Positive Economic Sentiment and Speculation of Interest Rate Hikes.

7.09.2026 г., 23:31 ч. UTC

ECB President Lagarde's Upcoming Speech Sparks Market Anticipation for Rate Hike Amid Rising Inflation and Geopolitical Tensions.

7.09.2026 г., 23:21 ч. UTC

U.S. Core Inflation Rate Expected to Rise to 2.4% YoY Amid Strong Jobs Data, Heightening Speculation on Fed Interest Rate Hikes

7.09.2026 г., 23:21 ч. UTC

Core Inflation Rate Release on September 11, 2026, Expected to Influence Fed's Interest Rate Decisions Amid Rising Geopolitical Tensions and Oil Prices.

7.09.2026 г., 23:21 ч. UTC

Investors Brace for CPI Release Amid Rising Inflation Concerns and Fed Rate Hike Speculation on September 11, 2026.

7.09.2026 г., 23:21 ч. UTC

U.S. Inflation Rate Expected to Rise 0.4% in August Amid Concerns of Federal Reserve Interest Rate Hikes Following Strong Job Growth

7.09.2026 г., 23:21 ч. UTC

U.S. CPI Report on September 11, 2026 Expected to Show Inflation Rise Amid Market Caution and Fed Rate Hike Speculation

7.09.2026 г., 23:21 ч. UTC

U.S. Inflation Rate Expected to Rise 3.4% YoY, Heightening Fed Rate Hike Speculations Amid Geopolitical Tensions and Oil Price Surge

7.09.2026 г., 23:11 ч. UTC

U.S. Core Producer Prices Expected to Rise 0.3% in August Amid Geopolitical Tensions and Inflation Concerns

7.09.2026 г., 23:01 ч. UTC

U.S. Producer Price Inflation (PPI) MoM for August set to release on September 10, with a forecasted rise of 0.4% amid inflation concerns and potential Fed interest rate hikes due to geopolitical tensions affecting oil prices.

7.09.2026 г., 23:01 ч. UTC

NZD/JPY is lower today amid broader market volatility and geopolitical tensions following U.S. military actions against Iranian tankers. The pair remains near its one-month low.

7.09.2026 г., 23:01 ч. UTC

Correlated Moves

AUD/JPY is trading lower, continuing a decline since Friday's close amid geopolitical tensions affecting investor sentiment and energy supply concerns.

7.09.2026 г., 23:01 ч. UTC

Correlated Moves

GBP/JPY is declining amid heightened market volatility from geopolitical tensions and U.S. military actions, continuing lower since Friday's close.

7.09.2026 г., 23:01 ч. UTC

Correlated Moves

CAD/JPY is declining, continuing a downward trend since Friday's close, influenced by geopolitical tensions and market volatility. The pair trades below its 20-day moving average.

7.09.2026 г., 23:01 ч. UTC

Macro News

The USD/JPY currency pair is trading lower as the yen strengthens amid global economic uncertainties and tensions in the Middle East.

7.09.2026 г., 23:01 ч. UTC

Correlated Moves

The EUR/JPY is lower today amid rising geopolitical tensions and a drop in USD/JPY. The exchange rate remains below its 20-day moving average.

7.09.2026 г., 23:01 ч. UTC

Correlated Moves

CHF/JPY is trading lower as geopolitical tensions influence market sentiment, following a notable decline earlier in the session. The pair remains below its 20-day moving average.

7.09.2026 г., 22:51 ч. UTC

Markets Anticipate ECB Deposit Facility Rate Hike Amid Rising Inflation and Geopolitical Tensions Ahead of September 10 Meeting.

7.09.2026 г., 22:21 ч. UTC

India's Inflation Rate Release on September 14, 2026, Sparks Caution Amid Geopolitical Tensions and Rising Costs.

7.09.2026 г., 22:11 ч. UTC

Mexico's Inflation Rate YoY for August 2026 set to release on September 9, with a forecast of 3.30% amid rising global oil prices and geopolitical tensions.

7.09.2026 г., 22:11 ч. UTC

Mexico's Inflation Rate Expected to Rise 0.25% in August Amid Global Economic Pressures and U.S. Interest Rate Concerns.

7.09.2026 г., 22:01 ч. UTC

MBA 30-Year Mortgage Rate Release on September 9, Amid Rising Rates and Anticipated Fed Hikes Influenced by Inflation Concerns.

7.09.2026 г., 21:51 ч. UTC

Brazil's Central Bank to Announce Interest Rate Decision Amid Global Economic Uncertainty on September 8, 2026.

Сравнение с други в отрасъла

Ценова промяна

Zealand Pharma A-S Прогноза

Ценова цел

By TipRanks

25.15% нагоре

12-месечна прогноза

Среден 270.582 DKK 25.15%

Висок 270.568 DKK

Нисък 270.568 DKK

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за Zealand Pharma A-S през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

1 ratings

Купи

Задържане

Продай

Според 1 анализатори, дали борсови рейтинги на Zealand Pharma A-S през последните 3 месеца.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Zealand Pharma A-S

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company offers Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon that is in Phase III clinical trials for treating congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.